107 related articles for article (PubMed ID: 14752858)
1. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin.
Kismet E; Varan A; Ayabakan C; Alehan D; Portakal O; Büyükpamukçu M
Pediatr Blood Cancer; 2004 Mar; 42(3):220-4. PubMed ID: 14752858
[TBL] [Abstract][Full Text] [Related]
2. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
[TBL] [Abstract][Full Text] [Related]
3. Early myocardial injury in children on doxorubicin for cancer chemotherapy: a cross-sectional study in a tertiary referral centre in Kenya.
Kariuki N; Kimani E; Jowi C; Wamalwa D; Suen JY; Fraser JF; Obonyo NG
BMC Cardiovasc Disord; 2024 May; 24(1):260. PubMed ID: 38769516
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.
Herman EH; Zhang J; Lipshultz SE; Rifai N; Chadwick D; Takeda K; Yu ZX; Ferrans VJ
J Clin Oncol; 1999 Jul; 17(7):2237-43. PubMed ID: 10561281
[TBL] [Abstract][Full Text] [Related]
5. Early anthracycline-induced cardiotoxicity monitored by echocardiographic Doppler parameters combined with serum hs-cTnT.
Zhang CJ; Pei XL; Song FY; Guo Y; Zhang QL; Shu XH; Hsi DH; Cheng LL
Echocardiography; 2017 Nov; 34(11):1593-1600. PubMed ID: 28942608
[TBL] [Abstract][Full Text] [Related]
6. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.
Hattori K; Ishii T; Motegi T; Kusunoki Y; Gemma A; Kida K
Int J Chron Obstruct Pulmon Dis; 2015; 10():309-20. PubMed ID: 25709425
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of cardiac troponin T and I in hemodialysis patients.
Kalaji FR; Albitar S
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):939-45. PubMed ID: 22982904
[TBL] [Abstract][Full Text] [Related]
10. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
Löwbeer C; Gustafsson SA; Seeberger A; Bouvier F; Hulting J
Scand J Clin Lab Invest; 2004; 64(7):667-76. PubMed ID: 15513324
[TBL] [Abstract][Full Text] [Related]
11. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension.
Torbicki A; Kurzyna M; Kuca P; Fijałkowska A; Sikora J; Florczyk M; Pruszczyk P; Burakowski J; Wawrzyńska L
Circulation; 2003 Aug; 108(7):844-8. PubMed ID: 12900346
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of high-sensitivity cardiac troponin T in patients with dilated cardiomyopathy.
Baba Y; Kubo T; Yamanaka S; Hirota T; Tanioka K; Yamasaki N; Sugiura T; Kitaoka H
Int Heart J; 2015 May; 56(3):309-13. PubMed ID: 25912901
[TBL] [Abstract][Full Text] [Related]
13. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.
Lipshultz SE; Rifai N; Sallan SE; Lipsitz SR; Dalton V; Sacks DB; Ottlinger ME
Circulation; 1997 Oct; 96(8):2641-8. PubMed ID: 9355905
[TBL] [Abstract][Full Text] [Related]
15. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.
Bossi G; Lanzarini L; Laudisa ML; Klersy C; Raisaro A; Aricò M
Med Pediatr Oncol; 2001 Jun; 36(6):593-600. PubMed ID: 11344489
[TBL] [Abstract][Full Text] [Related]
17. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies.
Auner HW; Tinchon C; Linkesch W; Tiran A; Quehenberger F; Link H; Sill H
Ann Hematol; 2003 Apr; 82(4):218-22. PubMed ID: 12679885
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiac troponin I and T, including the evaluation of an ultrasensitive assay, as indicators of doxorubicin-induced cardiotoxicity.
Reagan WJ; York M; Berridge B; Schultze E; Walker D; Pettit S
Toxicol Pathol; 2013; 41(8):1146-58. PubMed ID: 23531791
[TBL] [Abstract][Full Text] [Related]
20. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
